These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14762905)

  • 1. Rationalizing the structural properties of bupivacaine base--a local anesthetic--directly from powder X-ray diffraction data.
    Cheung EY; Harris KD; Johnston RL; Kitchin SJ; Hadden KL; Zakrzewski M
    J Pharm Sci; 2004 Mar; 93(3):667-74. PubMed ID: 14762905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism of a novel sodium ion channel blocker.
    Cheung EY; Harris KD; Johnston RL; Hadden KL; Zakrzewski M
    J Pharm Sci; 2003 Oct; 92(10):2017-26. PubMed ID: 14502541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Powder diffraction crystallography of molecular solids.
    Harris KD
    Top Curr Chem; 2012; 315():133-77. PubMed ID: 21952843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.
    Brüning J; Schmidt MU
    J Pharm Pharmacol; 2015 Jun; 67(6):773-81. PubMed ID: 25677117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational analysis of an acyclic tetrapeptide: ab-initio structure determination from X-ray powder diffraction, Hirshfeld surface analysis and electronic structure.
    Das U; Naskar J; Mukherjee AK
    J Pept Sci; 2015 Dec; 21(12):845-52. PubMed ID: 26434376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of four crystal polymorphs and a monohydrate of s-bupivacaine hydrochloride (levobupivacaine hydrochloride).
    Niederwanger V; Gozzo F; Griesser UJ
    J Pharm Sci; 2009 Mar; 98(3):1064-74. PubMed ID: 18729201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the structural properties of a dendrimeric material directly from powder X-ray diffraction data.
    Pan Z; Xu M; Cheung EY; Harris KD; Constable EC; Housecroft CE
    J Phys Chem B; 2006 Jun; 110(24):11620-3. PubMed ID: 16800454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of bupivacaine decorated reduced graphene oxide and its local anesthetic effect-In vivo study.
    Zhang Z; Zhang X; Li A; Ma C
    J Photochem Photobiol B; 2018 Mar; 180():72-76. PubMed ID: 29413704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of bupivacaine-loaded formulations based on liquid crystalline phases and microemulsions: the effect of lipid composition.
    Yaghmur A; Rappolt M; Østergaard J; Larsen C; Larsen SW
    Langmuir; 2012 Feb; 28(5):2881-9. PubMed ID: 22247936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic products in coordination networks: ab initio X-ray powder diffraction analysis.
    Martí-Rujas J; Kawano M
    Acc Chem Res; 2013 Feb; 46(2):493-505. PubMed ID: 23252592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct structure determination of a multicomponent molecular crystal prepared by a solid-state grinding procedure.
    Cheung EY; Kitchin SJ; Harris KD; Imai Y; Tajima N; Kuroda R
    J Am Chem Soc; 2003 Dec; 125(48):14658-9. PubMed ID: 14640612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ab initio structure determination of anhydrous sodium alendronate from laboratory powder X-ray diffraction data.
    Asnani M; Vyas K; Bhattacharya A; Devarakonda S; Chakraborty S; Mukherjee AK
    J Pharm Sci; 2009 Jun; 98(6):2113-21. PubMed ID: 18781644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ab initio structure determination of phase II of racemic ibuprofen by X-ray powder diffraction.
    Derollez P; Dudognon E; Affouard F; Danède F; Correia NT; Descamps M
    Acta Crystallogr B; 2010 Feb; 66(Pt 1):76-80. PubMed ID: 20101086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray powder diffraction data for seventeen local anesthetics.
    Owen JT; Sithiraks R; Underwood FA
    J Assoc Off Anal Chem; 1972 Nov; 55(6):1171-4. PubMed ID: 4669099
    [No Abstract]   [Full Text] [Related]  

  • 16. Rietveld refinement of a wrong crystal structure.
    Buchsbaum C; Schmidt MU
    Acta Crystallogr B; 2007 Dec; 63(Pt 6):926-32. PubMed ID: 18004047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine.
    Pachuk CJ; Ciccarelli RB; Samuel M; Bayer ME; Troutman RD; Zurawski DV; Schauer JI; Higgins TJ; Weiner DB; Sosnoski DM; Zurawski VR; Satishchandran C
    Biochim Biophys Acta; 2000 Sep; 1468(1-2):20-30. PubMed ID: 11018648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of L-arginine.
    Courvoisier E; Williams PA; Lim GK; Hughes CE; Harris KD
    Chem Commun (Camb); 2012 Mar; 48(22):2761-3. PubMed ID: 22297609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the density of bupivacaine and bupivacaine-opioid combinations.
    Hallworth SP; Fernando R; Stocks GM
    Anesth Analg; 2002 Jun; 94(6):1621-4, table of contents. PubMed ID: 12032040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkalinization of local anesthetics. Which block, which local anesthetic?
    Capogna G; Celleno D; Laudano D; Giunta F
    Reg Anesth; 1995; 20(5):369-77. PubMed ID: 8519712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.